Testen Sie Ihr Fachwissen

• Literatur

• 1 Quinn MJ, Crotty KA, Thompson JF et al. Desmoplastic and desmoplastic neurotropic melanoma: experience with 280 patients. Cancer 1998; 83: 1128-1135
• 2 Livestro DP, Muzikansky A, Kaine EM et al. Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol 2005; 23: 6739-6746
• 3 Bastos Junior Cde S, Piñeiro-Maceira JM, Moraes FM. Desmoplastic melanoma associated with an intraepidermal lentiginous lesion: case report and literature review. An Bras Dermatol 2013; 88: 408-412
• 4 Chen LL, Jaimes N, Barker CA. Desmoplastic melanoma: a review. J Am Acad Dermatol 2013; 68: 825-833
• 5 Murali R, Shaw HM, Lai K et al. Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer 2010; 116: 4130-4138
• 6 Busam KJ, Mujumdar U, Hummer AJ et al. Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 2004; 28: 1518-1525
• 7 Hawkins WG, Busam KJ, Ben-Porat L et al. Desmoplastic melanoma: a pathologically and clinically distinct form of cutaneous melanoma. Ann Surg Oncol 2005; 12: 207-213
• 8 Smithers BM, McLeod GR, Little JH. Desmoplastic melanoma: patterns of recurrence. World J Surg 1992; 16: 186-190
• 9 Jaroszewski DE, Pockaj BA, DiCaudo DJ, Bite U. The clinical behavior of desmoplastic melanoma. Am J Surg 2001; 182: 590-595
• 10 Gyorki DE, Busam K, Panageas K et al. Sentinel lymph node biopsy for patients with cutaneous desmoplastic melanoma. Ann Surg Oncol 2003; 10: 403-407
• 11 Malignes Melanom S3-Leitlinie „Diagnostik, Therapie und Nachsorge des Melanoms“. Version 1.1 – Februar 2013. AWMF-Register-Nummer: 032-024OL